The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1527
August 14, 2017
View Complete Issue         Table of Contents 2019 
Safety of Long-Term PPI Use
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Safety of Long-Term PPI Use
August 14, 2017 (Issue: 1527)
Proton pump inhibitors (PPIs), which are used for treatment of gastroesophageal reflux disease (GERD) and for prevention of upper gastrointestinal adverse effects caused by NSAIDs and aspirin, are one of the most commonly prescribed classes of...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Safety of Long-Term PPI Use
Article code: 1527a
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.